American Heart Journal
Volume 156, Issue 6 , Pages 1201.e1-1201.e11 , December 2008

Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease: The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study

  • Renate Schnabel, MD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • Both authors contributed equally.
    • ,
  • Edith Lubos, MD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • Both authors contributed equally.
    • ,
  • Claudia M. Messow

      Affiliations

    • The Institute of Medical Biostatistics, Epidemiology and Informatics, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Christoph R. Sinning, MD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Tanja Zeller, PhD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Philipp S. Wild, MD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Dirk Peetz, MD

      Affiliations

    • The Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Diane E. Handy, PhD

      Affiliations

    • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Thomas Munzel, MD, FAHA

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Joseph Loscalzo, MD, PhD

      Affiliations

    • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Karl J. Lackner, MD

      Affiliations

    • The Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University, Mainz, Germany
    • ,
  • Stefan Blankenberg, MD

      Affiliations

    • Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany
    • Corresponding Author InformationReprint requests: Stefan Blankenberg, MD, Department of Medicine II, Johannes Gutenberg-University, Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.

Received 17 June 2008 ,Accepted 8 September 2008.

References 

  1. Flohe L. Glutathione peroxidase. Basic Life Sci. 1988;49:663–668
  2. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27:916–921
  3. Weiss N, Zhang YY, Heydrick S, et al. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A. 2001;98:12503–12508
  4. Forgione MA, Cap A, Liao R, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation. 2002;106:1154–1158
  5. de Haan JB, Bladier C, Griffiths P, et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem. 1998;273:22528–22536
  6. Fu Y, Cheng WH, Porres JM, et al. Knockout of cellular glutathione peroxidase gene renders mice susceptible to diquat-induced oxidative stress. Free Radic Biol Med. 1999;27:605–611
  7. Forgione MA, Weiss N, Heydrick S, et al. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2002;282:H1255–H1261
  8. Imanaka-Yoshida K, Amitani A, Ioshii SO, et al. Alterations of expression and distribution of the Ca(2+)-storing proteins in endo/sarcoplasmic reticulum during differentiation of rat cardiomyocytes. J Mol Cell Cardiol. 1996;28:553–562
  9. Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003;349:1605–1613
  10. Schnabel R, Lackner KJ, Rupprecht HJ, et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol. 2005;45:1631–1637
  11. Alfthan G, Neve J. Reference values for serum selenium in various areas-evaluated according to the TRACY protocol. J Trace Elem Med Biol. 1996;10:77–87
  12. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241
  13. Salonen JT, Alfthan G, Huttunen JK, et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2:175–179
  14. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985;56:226–231
  15. Virtamo J, Valkeila E, Alfthan G, et al. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol. 1985;122:276–282
  16. Kardinaal AF, Kok FJ, Kohlmeier L, et al. Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. Am J Epidemiol. 1997;145:373–379
  17. Navarro-Alarcon M, Lopez-Garcia de la Serrana H, Perez-Valero V, et al. Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes. Ann Nutr Metab. 1999;43:30–36
  18. Kok FJ, Hofman A, Witteman JC, et al. Decreased selenium levels in acute myocardial infarction. Jama. 1989;261:1161–1164
  19. Stranges S, Marshall JR, Trevisan M, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006;163:694–699
  20. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol. 1984;105:114–121
  21. Warnholtz A, Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention–induced endothelial dysfunction in patients with stable coronary artery disease. Am J Cardiol. 2005;95:20–23
  22. Duffield AJ, Thomson CD, Hill KE, et al. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr. 1999;70:896–903
  23. Arnaud J, Bertrais S, Roussel AM, et al. Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr. 2006;95:313–320
  24. Galan P, Viteri FE, Bertrais S, et al. Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr. 2005;59:1181–1190
  25. Niskar AS, Paschal DC, Kieszak SM, et al. Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. Biol Trace Elem Res. 2003;91:1–10
  26. Kimmons JE, Blanck HM, Tohill BC, et al. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed. 2006;8:59
  27. de Cavanagh EM, Inserra F, Ferder L, et al. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol. 2000;278:R572–R577
  28. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3:42–47
  29. Brigelius-Flohe R, Banning A, Schnurr K. Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal. 2003;5:205–215
  30. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, et al. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84:762–773
  31. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164:2335–2342
  32. You WC, Chang YS, Heinrich J, et al. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur J Cancer Prev. 2001;10:257–263
  33. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592
  34. Kuklinski B, Weissenbacher E, Fahnrich A. Coenzyme Q10 and antioxidants in acute myocardial infarction. Mol Aspects Med. 1994;15(Suppl):S143–S147
  35. Korpela H, Kumpulainen J, Jussila E, et al. Effect of selenium supplementation after acute myocardial infarction. Res Commun Chem Pathol Pharmacol. 1989;65:249–252
  36. Bor MV, Cevik C, Uslu I, et al. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol. 1999;54:271–276
  37. Nichol C, Herdman J, Sattar N, et al. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response?. Clin Chem. 1998;44(8 Pt 1):1764–1766
  38. Spallholz JE, Palace VP, Reid TW. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem Pharmacol. 2004;67:547–554
  39. Thomson CD, Burton CE, Robinson MF. On supplementing the selenium intake of New Zealanders. 1. Short experiments with large doses of selenite or selenomethionine. Br J Nutr. 1978;39:579–587
  40. Thomson CD, Robinson MF, Campbell DR, et al. Effect of prolonged supplementation with daily supplements of selenomethionine and sodium selenite on glutathione peroxidase activity in blood of New Zealand residents. Am J Clin Nutr. 1982;36:24–31
  41. Murias M, Rachtan M, Jodynis-Liebert J. Effect of multiple freeze-thaw cycles of cytoplasm samples on the activity of antioxidant enzymes. J Pharmacol Toxicol Methods. 2005;52:302–305
  42. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol. 1984;105:114–121
  43. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169
  44. Warnholtz A, Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention–induced endothelial dysfunction in patients with stable coronary artery disease. Am J Cardiol. 2005;95:20–23
  45. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265

 The study was funded by an unrestricted grant from Biosyn Arzneimittel GmbH, Fellbach, Germany; by National Institutes of Health (NIH) (Bethesda, MD) grants HL 61795, HV 28178, and HL 81587 from the National Heart, Lung, and Blood Institute (J.L.) (Bethesda, MD); and by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany) LU 1452/1-1 (E.L.) and SCHN 1149/1-1 (R.S.).

PII: S0002-8703(08)00789-8

doi: 10.1016/j.ahj.2008.09.004

American Heart Journal
Volume 156, Issue 6 , Pages 1201.e1-1201.e11 , December 2008

Article Tools

* Image Usage & Resolution